We need around 140 donations in the next four days to succeed with
our September fundraising challenge! We're striving for 818 unique
contributions before September 30th, which would make this the most
contributions we've ever received in a single month.
It's a challenge to do fundraising for Erowid Center. Many people ask
why we need money at all. Some feel that obtaining donations should
be easy for us, given the number of visitors who use the site. Still
others believe that we receive funding from the government.
Erowid is a small non-profit that depends entirely on donations from
people like you in order to continue to document psychoactive
drugs. We have a relatively modest budget, but we do need to pay our
staff (the equivalent of 3.5 full-time people) who work hard every
day to keep the site up-to-date, check facts, track emerging drugs
and drug trends, and keep the servers up, running, and secure.
Please support Erowid with a contribution of any size in September!
https://erowid.org/donations/sept_drive.php
Erowid Monthly
|
Drug Geek Factlet
The death of 18-year-old American Kyle Nolan is drawing attention
after he traveled to the Madre de Dios region of Peru to attend an
ayahuasca retreat and died under unknown conditions. Shockingly, the
shaman in charge of the retreat buried his body and lied to family
members for more than two weeks before leading police to the body.
Nolan's father held a fundraiser to cover costs to bring the body
home for further autopsy while toxicology results are pending in Peru.
Events
Rencontres Nationales de la Réduction des Risques Liés à l'Usage de Drogues
(Oct 25-26, 2012) in Paris, France http://rdr2012.a-f-r.org Plenaries, panels, posters, and exhibitions on harm reduction projects and policies in francophone Europe (esp. France). Hosted by l'Association Franç¨aise pour la Rˇéduction des risques [AFR; French Association for Risk Reduction]. Latest Additions
Crew Notes
In June, Erowid crew members Jon Hanna and Tania Manning interviewed
Dr. David Nichols just before he retired from his position as Chair
in Pharmacology at Purdue University College of Pharmacy's Department
of Medicinal Chemistry and Molecular Pharmacology. Highlights of this
interview will appear in the November issue of Erowid Extracts. One
of the topics discussed was Nichols' work with LSD analogs:
"LSD sorta violates the principles of medicinal chemistry. You expect to see potency change in a regular way. When you see it change very abruptly, that's when there must be some sensitive spot, or there's a steric restriction, or something. So we did a lot of amide modification, and made a lot of derivative analogs of LSD. We still don't know why LSD is as potent as it is. But it interacts with a lot of different receptors." The Erowid crew wishes Dr. Dave the best with his new position at the University of North Carolina at Chapel Hill. From the Vaults
More New Content
Experience Reports
(see 19 new) Ecstasy Data
(see 21 new results)
EcstasyData is a project of Erowid Center that conducts laboratory
testing of street ecstasy tablets and publishes these and other test
results online.
Donate Or Become A Member
If you find Erowid a useful resource and are interested in supporting
its future development, please consider donating or becoming a member.
Donations to Erowid Center are tax-deductible in the United States.
List Subscription Information
|
